AIM: To evaluate the clinical efficacy and safety of salmeterol xinafoate and fluticasone propionate in the treatment of moderate and severe asthma children.

• 方法:将80例中、重度哮喘病儿分成沙美特罗替卡松粉吸入剂治疗组(治疗组)和氟替卡松治疗组(对照组)。